Director dealings: Redx Pharma CEO ups stake
12th Apr 2024 15:35
(Sharecast News) - Redx Pharma revealed on Friday that chief executive Lisa Anson had acquired 399,000 ordinary shares in the AIM-listed clinical-stage biopharmaceutical firm.
Read moreJounce agrees Concentra Bioscences takeover, ditches Redx Pharma
27th Mar 2023 14:16
(Sharecast News) - Jounce Therapeutics said on Monday that it was ditching a planned merger with AIM-listed Redx Pharma, opting instead to be bought by Concentra Bioscences.
Read moreDirector dealings: Redx CEO ups stake
23rd Dec 2020 15:52
(Sharecast News) - Redx Pharma revealed on Wednesday that chief executive Lisa Anson had acquired 39,998 ordinary shares in the AIM-listed drug discovery and development group.
Read moreRedx signs new collaboration deal with Jazz Pharmaceuticals
9th Sep 2020 12:26
(Sharecast News) - Drug discovery and development company Redx Pharma has signed a new research collaboration agreement with Jazz Pharmaceuticals to discover and develop drug candidates for two cancer targets on the Ras/Raf/MAP kinase (MAPK) pathway.
Read moreRedx Pharma surges on AstraZeneca licensing agreement
4th Aug 2020 08:45
(Sharecast News) - Redx Pharma shares soared on Tuesday after it signed a licensing agreement with AstraZeneca for its porcupine inhibitor for fibrotic diseases, RXC006.
Read moreRedx shares surge on possible cash offer from Yesod
13th Mar 2020 10:31
(Sharecast News) - Drug discovery and development company Redx Pharma has received a further private approach from Yesod Bio-Sciences, it announced on Friday, that could lead to a possible cash offer for the entire issued and to be issued share capital of the company, at a price of 15p per share.
Read moreRedx Pharma nominates next drug development candidate
9th Jan 2020 16:02
(Sharecast News) - Drug discovery and development company Redx Pharma announced the nomination of RXC007 as its next drug development candidate for the treatment of fibrosis on Thursday.
Read moreRedx collaboration with MDC awarded Innovate UK funding
19th Nov 2019 12:29
(Sharecast News) - Redx Pharma announced on Tuesday that Innovate UK has awarded biomedical catalyst funding to Redx and Medicines Discovery Catapult (MCD).
Read moreRedx Pharma gets green light to escalate dose in RXC004 study
19th Aug 2019 09:43
(Sharecast News) - Drug discovery and development company Redx Pharma has successfully completed dosing of the first cohort of patients in its ongoing phase 1 and 2 study with 'RXC004', it announced on Monday.
Read moreRedx Pharma narrows losses as RXC004 trials recommence
10th Jun 2019 08:29
(Sharecast News) - Drug discovery and development company Redx Pharma published its interim results on Monday, revealing it had narrowed first-half losses as it progresses on cancer and idiopathic pulmonary fibrosis drugs development.
Read moreRedx Pharma extends cash runway into July
3rd May 2019 11:17
(Sharecast News) - Drug discovery and development company Redx Pharma updated the market on its ongoing plans to strengthen its balance sheet on Friday, with its board reiterating its commitment to strengthening the balance sheet in order to extend the cash runway beyond the second quarter of 2019, as it initially announced in November.
Read moreRedx Pharma reveals promising data on 'ROCK2' compound
12th Feb 2019 13:42
(Sharecast News) - Drug discovery and development company Redx Pharma announced promising preclinical efficacy data for its lead selective 'ROCK2' compound on Tuesday.
Read moreDeinove hands rights to NBTI programme back to Redx Pharma
31st Jan 2019 09:45
(Sharecast News) - Drug discovery and development company Redx Pharma announced on Thursday that Deinove had decided not to exercise its option for Redx's 'Novel Bacterial Topoisomerase Inhibitor' (NBTI) programme.
Read moreRedx Pharma jumps as first data shows 'great potential' for fibrosis candidate
30th Nov 2018 10:31
(Sharecast News) - Redx Pharma made gains on Friday after it said that pre-clinical data suggested that its RXC006 drug candidate has "great potential" as a treatment for fibrosis.
Read moreRedx Pharma swings to a loss following 'seminal' year
19th Nov 2018 08:59
(Sharecast News) - A year after clambering out of administration, drug discovery and development outfit Redx Pharma swung to a loss but remains confident of making progress with a drug pipeline refocused on cancer and fibrosis.
Read more